Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Implantable Insulin Pump Market by Type (Closed-Loop Insulin Pump, Open-Loop Insulin Pump), By Application (Hospitals, Individuals (Self-Medication)) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Implantable Insulin Pump Market by Type (Closed-Loop Insulin Pump, Open-Loop Insulin Pump), By Application (Hospitals, Individuals (Self-Medication)) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 196032 3300 Medical Devices & Consumables 377 234 Pages 5 (40)
                                          

The global implantable insulin pump market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of diabetes and rising awareness about the benefits of insulin pumps among patients with diabetes. The global implantable insulin pump market is segmented on the basis of type, application, and region. The close loop insulin pump segment accounted for a major share in 2018 owing to its ability to provide continuous glucose monitoring (CGM) data and reduce hypoglycemia risk by automatically adjusting basal rates based on CGM readings. The individual segment accounted for a major share in 2018 owing to its high adoption rate among patients with type 1 diabetes who are not using an external infusion device or an external infusion device that does not have a closed loop system. North America was estimated as the largest regional market in 2018 due to its high prevalence rate of diabetes and increasing awareness about benefits associated with implantable devices among patients with diabetes.

  1. The global population is aging and the number of people with diabetes is increasing.
  2. The cost of insulin has increased, which has led to a decrease in the use of injectable insulin and an increase in the use of oral medications for diabetes treatment.
  3. Insulin pumps are more convenient than injections, which may lead to an increase in their use among patients with type 1 diabetes mellitus (T1DM).
  4. Insulin pump therapy may be more effective than other treatments for T1DM because it can help control blood sugar levels better than other treatments, such as oral medications or injections alone.
  5. Insulin pumps are expensive and require a prescription from a doctor; however, they may be covered by insurance companies if they are prescribed by a doctor.

Industry Growth Insights published a new data on “Implantable Insulin Pump Market”. The research report is titled “Implantable Insulin Pump Market research by Types (Closed-Loop Insulin Pump, Open-Loop Insulin Pump), By Applications (Hospitals, Individuals (Self-Medication)), By Players/Companies Medtronic, Insulet Corporation, F. Hoffmann La Roche Ltd, Animas corporation, SOOIL Developments Co., Ltd, Johnson & Johnson, Tandem Diabetes Care, Inc, Aetna Inc”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Implantable Insulin Pump Market Research Report

By Type

Closed-Loop Insulin Pump, Open-Loop Insulin Pump

By Application

Hospitals, Individuals (Self-Medication)

By Companies

Medtronic, Insulet Corporation, F. Hoffmann La Roche Ltd, Animas corporation, SOOIL Developments Co., Ltd, Johnson & Johnson, Tandem Diabetes Care, Inc, Aetna Inc

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

234

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Implantable Insulin Pump Industry Outlook


Global Implantable Insulin Pump Market Report Segments:

The global Implantable Insulin Pump market is segmented on the basis of:

Types

Closed-Loop Insulin Pump, Open-Loop Insulin Pump

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Individuals (Self-Medication)

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Medtronic
  2. Insulet Corporation
  3. F. Hoffmann La Roche Ltd
  4. Animas corporation
  5. SOOIL Developments Co., Ltd
  6. Johnson & Johnson
  7. Tandem Diabetes Care, Inc
  8. Aetna Inc

Global Implantable Insulin Pump Market Overview


Highlights of The Implantable Insulin Pump Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Closed-Loop Insulin Pump
    2. Open-Loop Insulin Pump
  1. By Application:

    1. Hospitals
    2. Individuals (Self-Medication)
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Implantable Insulin Pump Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Implantable Insulin Pump Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


An implantable insulin pump is a medical device that helps people with diabetes manage their blood sugar levels. The pump is inserted under the skin in the stomach and connected to a computer, which monitors blood sugar levels. The patient can use the pump to administer insulin as needed.

Some of the major companies in the implantable insulin pump market are Medtronic, Insulet Corporation, F. Hoffmann La Roche Ltd, Animas corporation, SOOIL Developments Co., Ltd, Johnson & Johnson, Tandem Diabetes Care, Inc, Aetna Inc.

The implantable insulin pump market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Implantable Insulin Pump Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Implantable Insulin Pump Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Implantable Insulin Pump Market - Supply Chain
   4.5. Global Implantable Insulin Pump Market Forecast
      4.5.1. Implantable Insulin Pump Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Implantable Insulin Pump Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Implantable Insulin Pump Market Absolute $ Opportunity

5. Global Implantable Insulin Pump Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Implantable Insulin Pump Market Size and Volume Forecast by Type
      5.3.1. Closed-Loop Insulin Pump
      5.3.2. Open-Loop Insulin Pump
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Implantable Insulin Pump Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Implantable Insulin Pump Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Individuals (Self-Medication)
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Implantable Insulin Pump Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Implantable Insulin Pump Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Implantable Insulin Pump Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Implantable Insulin Pump Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Implantable Insulin Pump Demand Share Forecast, 2019-2026

9. North America Implantable Insulin Pump Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Implantable Insulin Pump Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Implantable Insulin Pump Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Individuals (Self-Medication)
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Implantable Insulin Pump Market Size and Volume Forecast by Type
      9.7.1. Closed-Loop Insulin Pump
      9.7.2. Open-Loop Insulin Pump
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Implantable Insulin Pump Demand Share Forecast, 2019-2026

10. Latin America Implantable Insulin Pump Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Implantable Insulin Pump Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Implantable Insulin Pump Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Individuals (Self-Medication)
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Implantable Insulin Pump Market Size and Volume Forecast by Type
      10.7.1. Closed-Loop Insulin Pump
      10.7.2. Open-Loop Insulin Pump
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Implantable Insulin Pump Demand Share Forecast, 2019-2026

11. Europe Implantable Insulin Pump Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Implantable Insulin Pump Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Implantable Insulin Pump Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Individuals (Self-Medication)
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Implantable Insulin Pump Market Size and Volume Forecast by Type
      11.7.1. Closed-Loop Insulin Pump
      11.7.2. Open-Loop Insulin Pump
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Implantable Insulin Pump Demand Share, 2019-2026

12. Asia Pacific Implantable Insulin Pump Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Implantable Insulin Pump Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Implantable Insulin Pump Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Individuals (Self-Medication)
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Implantable Insulin Pump Market Size and Volume Forecast by Type
      12.7.1. Closed-Loop Insulin Pump
      12.7.2. Open-Loop Insulin Pump
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Implantable Insulin Pump Demand Share, 2019-2026

13. Middle East & Africa Implantable Insulin Pump Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Implantable Insulin Pump Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Implantable Insulin Pump Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Individuals (Self-Medication)
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Implantable Insulin Pump Market Size and Volume Forecast by Type
      13.7.1. Closed-Loop Insulin Pump
      13.7.2. Open-Loop Insulin Pump
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Implantable Insulin Pump Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Implantable Insulin Pump Market: Market Share Analysis
   14.2. Implantable Insulin Pump Distributors and Customers
   14.3. Implantable Insulin Pump Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Medtronic
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Insulet Corporation
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. F. Hoffmann La Roche Ltd
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Animas corporation
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. SOOIL Developments Co., Ltd
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Johnson & Johnson
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Tandem Diabetes Care, Inc
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Aetna Inc
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us